期刊
JOURNAL OF ALZHEIMERS DISEASE
卷 18, 期 1, 页码 71-78出版社
IOS PRESS
DOI: 10.3233/JAD-2009-1125
关键词
Alzheimer's disease; dementia; isoprostanes; oxidative stress; vitamins
资金
- Wallenberg Consortium North
- Hjarnfonden
- Bertil Hllstens forskningsstiftelse
- Alzheimerfonden
- Swedish Research Council [2003-5546, 2006-6555]
- Stiftelsen Gamla Tjanarinnor
- Capios Forskningsstiftelse
- Gun och Bertil Stohnes Forskningsstiftelse
- Swedish Heart-Lung foundation
- Swedish Lions Research Foundation
- Erik
- Karin och Gosta Selanders Stiftelse
- Loo och Hans Ostermans stiftelse
Oxidative stress in the brain is suggested to be involved in the pathophysiology of Alzheimer's disease (AD). In this study, serum alpha- and gamma-tocopherol, the two major systemic antioxidants, were analyzed at two examinations of the ULSAM-study, a longitudinal, community-based study of elderly men (age 70, n = 616 and age 77, n = 761). In addition, urinary F-2-isoprostane levels, as markers of systemic oxidative stress, were analyzed at the age of 77 in this cohort (n = 679). Cox regression analyses were used to examine associations between serum alpha-, gamma-tocopherol and urinary F-2-isoprostane levels and AD, any type of dementia (all-cause dementia) and non-AD dementia. On follow-up (median, 12.3 years), 40 subjects developed AD and 86 subjects developed all-cause dementia. Serum alpha- and gamma-tocopherol or urinary F-2-isoprostane levels were not associated with the future risk of AD or dementia. In conclusion, systemic serum alpha- and gamma-tocopherol and urinary F-2-isoprostane levels are not associated with the future risk of AD or dementia and do not seem to be useful predictors of clinical AD or dementia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据